Skip to main content
Top
Published in: Rheumatology International 12/2017

01-12-2017 | Food for Thought

The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?

Authors: Mario Andrés Quintana-Duque, Federico Rondon-Herrera, Enrique Calvo-Paramo, Juan Jose Yunis, Adriana Varela-Nariño, Antonio Iglesias-Gamarra

Published in: Rheumatology International | Issue 12/2017

Login to get access

Abstract

The ojective of this study is to assess the effect of tobacco smoking on disease activity, functional ability, and joint damage in a cohort of patients with early onset rheumatoid arthritis (EORA). 129 EORA patients attending the Rheumatology Unit of the School of Medicine of the “Universidad Nacional de Colombia” and the “Clínica de Artritis y Rehabilitación” in Bogota, Colombia, were enrolled in a prospective observational cohort study with 3-year follow-up. Clinical, biological, immunogenetics, and radiographic data were analyzed. Active disease was defined as DAS28 > 2.6. Smoking status was assessed by self-report as “never smokers” and “ever smokers”. Patient groups with different smoking status were compared for RA measures. Status as “never smokers” and “ever smokers” was reported by 81.3 and 18.7%. Ever smokers had less risk of disability (HAQ-DI ≥ 0.5) at 36 month (Ever smokers vs. Never smokers OR for HAQ ≥ 0.5 0.25, 95% CI 0.06–0.97, p = 0.04). When former smokers were excluded in analysis, we found that current smoking was also associated with less disability and less risk of active disease. The percentage of erosive disease, radiographic progression, and SvdH score were similar in all smoking categories. In Colombian patients with EORA, smoking was associated with less disease activity and disability. Radiographic joint damage progressed at an equivalent rate in smokers and non-smokers. These data suggest a more benign, or at least not deleterious clinical course in smokers with RA.
Literature
1.
go back to reference Sugiyama D, Nishimura K, Tamaki K et al (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69:70–81CrossRefPubMed Sugiyama D, Nishimura K, Tamaki K et al (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69:70–81CrossRefPubMed
2.
go back to reference Hutchinson D, Shepstone L, Moots R et al (2001) Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 60:223–227CrossRefPubMedPubMedCentral Hutchinson D, Shepstone L, Moots R et al (2001) Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 60:223–227CrossRefPubMedPubMedCentral
3.
go back to reference Turesson C, O’Fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: induce trends and risk factors over 46 years. Ann Rheum Dis 62:722–727CrossRefPubMedPubMedCentral Turesson C, O’Fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: induce trends and risk factors over 46 years. Ann Rheum Dis 62:722–727CrossRefPubMedPubMedCentral
4.
go back to reference Harrison BJ, Silman AJ, Wiles NJ et al (2001) The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 44:323–330CrossRefPubMed Harrison BJ, Silman AJ, Wiles NJ et al (2001) The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 44:323–330CrossRefPubMed
5.
go back to reference Mattey DL, Hutchinson D, Dawes PT et al (2002) Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 46:640–646CrossRefPubMed Mattey DL, Hutchinson D, Dawes PT et al (2002) Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 46:640–646CrossRefPubMed
6.
go back to reference Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA et al (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65:366–371CrossRefPubMed Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA et al (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65:366–371CrossRefPubMed
7.
go back to reference Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van AH et al (2007) Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA–DRB1 shared epitope alleles. Arthritis Rheum 56:2913–2918CrossRefPubMed Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van AH et al (2007) Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA–DRB1 shared epitope alleles. Arthritis Rheum 56:2913–2918CrossRefPubMed
8.
go back to reference Söderlin MK, Petersson IF, Geborek P (2012) The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scand J Rheumatol 41:1–9CrossRefPubMed Söderlin MK, Petersson IF, Geborek P (2012) The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scand J Rheumatol 41:1–9CrossRefPubMed
9.
go back to reference Wolfe F (2000) The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 27:630–637PubMed Wolfe F (2000) The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 27:630–637PubMed
10.
go back to reference Forslind K, Ahlmen M, Eberhardt K et al (2004) Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63:1090–1095CrossRefPubMedPubMedCentral Forslind K, Ahlmen M, Eberhardt K et al (2004) Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63:1090–1095CrossRefPubMedPubMedCentral
11.
go back to reference Wolfe F, Zwillich SH (1998) The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum 41:1072–1082CrossRefPubMed Wolfe F, Zwillich SH (1998) The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum 41:1072–1082CrossRefPubMed
12.
go back to reference Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H et al (2002) Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 46:913–920CrossRefPubMed Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H et al (2002) Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 46:913–920CrossRefPubMed
13.
go back to reference Centers for Disease Control. (2002) Cigarette smoking among adults—United States, 2000. Morbidity and Mortality Weekly Report, 51, pp 642–645 Centers for Disease Control. (2002) Cigarette smoking among adults—United States, 2000. Morbidity and Mortality Weekly Report, 51, pp 642–645
14.
go back to reference Westhoff G, Rau R, Zink A (2008) Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 47:849–854CrossRef Westhoff G, Rau R, Zink A (2008) Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 47:849–854CrossRef
15.
go back to reference Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M et al (2006) The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 45:734–740CrossRef Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M et al (2006) The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 45:734–740CrossRef
16.
go back to reference Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D et al (2008) Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 67:1529–1534CrossRefPubMedPubMedCentral Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D et al (2008) Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 67:1529–1534CrossRefPubMedPubMedCentral
17.
go back to reference Ruiz-Esquide V, Gómez-Puerta JA, Cañete JD, Graell E, Vazquez I, Ercilla MG et al (2011) Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis. J Rheumatol 38:2536–2539CrossRefPubMed Ruiz-Esquide V, Gómez-Puerta JA, Cañete JD, Graell E, Vazquez I, Ercilla MG et al (2011) Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis. J Rheumatol 38:2536–2539CrossRefPubMed
18.
go back to reference Vesperini V, Lukas C, Fautrel B, Le Loet X, Rincheval N, Combe B (2013) Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort. Arthritis Care Res (Hoboken) 65:1899–1906CrossRef Vesperini V, Lukas C, Fautrel B, Le Loet X, Rincheval N, Combe B (2013) Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort. Arthritis Care Res (Hoboken) 65:1899–1906CrossRef
19.
go back to reference Finckh A, Dehler S, Costenbader KH, Gabay C (2007) Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis 66:1066–1071CrossRefPubMedPubMedCentral Finckh A, Dehler S, Costenbader KH, Gabay C (2007) Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis 66:1066–1071CrossRefPubMedPubMedCentral
20.
go back to reference Mattey DL, Brownfield A, Dawes PT (2009) Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. J Rheumatol 36:1180–1187CrossRefPubMed Mattey DL, Brownfield A, Dawes PT (2009) Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. J Rheumatol 36:1180–1187CrossRefPubMed
22.
go back to reference Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarrsson H (2000) Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 39:1202–1205CrossRef Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarrsson H (2000) Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 39:1202–1205CrossRef
22.
go back to reference Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA (1997) Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 56:463–469CrossRefPubMedPubMedCentral Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA (1997) Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 56:463–469CrossRefPubMedPubMedCentral
23.
go back to reference Wang H, Yu M, Ochani M, Amella C, Tanovic M, Susarla S et al (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:84–388 Wang H, Yu M, Ochani M, Amella C, Tanovic M, Susarla S et al (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:84–388
24.
go back to reference Zhou Y, Zuo X, Li Y, Wang Y, Zhao H, Xiao X (2012) Nicotine inhibits tumor necrosis factor-a induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatol Int 32:97–104CrossRefPubMed Zhou Y, Zuo X, Li Y, Wang Y, Zhao H, Xiao X (2012) Nicotine inhibits tumor necrosis factor-a induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatol Int 32:97–104CrossRefPubMed
25.
go back to reference Ng M, Freeman MK, Fleming TD et al (2014) Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA 311(2):183–192CrossRefPubMed Ng M, Freeman MK, Fleming TD et al (2014) Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA 311(2):183–192CrossRefPubMed
Metadata
Title
The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?
Authors
Mario Andrés Quintana-Duque
Federico Rondon-Herrera
Enrique Calvo-Paramo
Juan Jose Yunis
Adriana Varela-Nariño
Antonio Iglesias-Gamarra
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3845-8

Other articles of this Issue 12/2017

Rheumatology International 12/2017 Go to the issue

Acknowledgement to Referees

Acknowledgement to referees

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.